{"id":"sr:improving-cancer-outcomes-screening-reporting-regulations-2018","name":"Improving Cancer Outcomes (Screening Reporting) Regulations 2018","slug":"improving-cancer-outcomes-screening-reporting-regulations-2018","collection":"regulation","jurisdiction":"vic","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":184182,"registerId":"vic-sr:improving-cancer-outcomes-screening-reporting-regulations-2018-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Improving Cancer Outcomes (Screening Reporting) Regulations 2018","content":"Version No. 002\n\n**Improving Cancer Outcomes (Screening Reporting) Regulations 2018**\n\n**S.R. No. 107/2018**\n\nVersion incorporating amendments as at  \n1 July 2019\n\n**TABLE OF PROVISIONS**\n\n*Regulation Page*\n\n1 Objective 1\n\n2 Authorising provision 1\n\n3 Commencement 1\n\n4 Revocations 1\n\n5 Definition 2\n\n6 Types of cancer screening to be reported 2\n\n7 Entities required to report cancer screening 2\n\n8 Cancer screening reports 2\n\nSchedule 1—Prescribed information to be set out in a report of cancer screening of the breast 3\n\n═════════════\n\nEndnotes 5\n\n1 General information 5\n\n2 Table of Amendments 7\n\n3 Amendments Not in Operation 8\n\n4 Explanatory details 9\n\n**Version No.** **002**\n\n**Improving Cancer Outcomes (Screening Reporting) Regulations 2018**\n\n**S.R. No. 107/2018**\n\nVersion incorporating amendments as at  \n1 July 2019\n\n\t1 Objective\n\nThe objective of these Regulations is to prescribe for the purposes of the **Improving Cancer Outcomes Act 2014**—\n\n(a) the types of cancer screening that are required to be reported to the Secretary; and\n\n(b) who must report that screening; and\n\n(c) the form of the reports, the time within which they must be made and the information to be included in them.\n\n\t2 Authorising provision\n\nThese Regulations are made under section 28 of the **Improving Cancer Outcomes Act 2014**.\n\n\t3 Commencement\n\nThese Regulations come into operation on  \n30 July 2018.\n\n\t4 Revocations\n\nThe following Regulations are **revoked**—\n\n(a) the Improving Cancer Outcomes (Screening Reporting) Regulations 2015[[1]](#endnote-1);\n\n(b) the Improving Cancer Outcomes (Screening Reporting) Amendment Regulations 2017[[2]](#endnote-2).\n\nReg. 5 substituted by S.R. No. 50/2019 reg. 5.\n\n\t5 Definition\n\nIn these Regulations—\n\n***healthcare identifier*** has the same meaning as in the Healthcare Identifiers Act 2010 of the Commonwealth.\n\nReg. 6 substituted by S.R. No. 50/2019 reg. 6.\n\n\t6 Types of cancer screening to be reported\n\nFor the purposes of section 8(1) of the **Improving Cancer Outcomes Act 2014**, mammography, mammographic screening and subsequent radiology, pathology or clinical testing or procedures undergone in order to determine whether an individual has cancer, or a precursor to cancer, of the breast are prescribed types of cancer screening.\n\nReg. 7 substituted by S.R. No. 50/2019 reg. 6.\n\n\t7 Entities required to report cancer screening\n\nFor the purposes of section 8(1) of the **Improving Cancer Outcomes Act 2014**, an organisation that conducts, on behalf of BreastScreen Victoria Inc, cancer screening of a type referred to in regulation 6 is a prescribed organisation.\n\nReg. 8 substituted by S.R. No. 50/2019 reg. 6.\n\n\t8 Cancer screening reports\n\nFor the purposes of section 8(2) of the **Improving Cancer Outcomes Act 2014**—\n\n(a) a report of the cancer screening is in the prescribed form if it contains the prescribed information; and\n\n(b) the prescribed information to be included in a report of the cancer screening of the type referred to in regulation 6 is the information set out in Schedule 1.\n\nSch. 1 amended by S.R. No. 50/2019 reg. 7.\n\nSchedule 1—Prescribed information  \nto be set out in a report of cancer screening of the breast\n\nRegulation 8\n\n1. Name of organisation where the test was undertaken\n\n2. Patient details:\n\nHealthcare identifier (*if known*)\n\nFamily name\n\nGiven name(s)\n\nMaiden name (*if applicable*)\n\nAddress (*home and postal*)\n\nPostcode\n\nContact telephone number (*home and mobile*)\n\nEmail address\n\nDate of birth\n\nCountry of birth\n\nAboriginal or Torres Strait Islander status\n\nLanguage spoken at home (*if known—please specify*)\n\n3. Breast cancer history:\n\nPatient\n\nPatient's family\n\n4. Symptoms of breast cancer\n\n5. Type of test\n\n6. Test result\n\nSch. 2 revoked by S.R. No. 50/2019 reg. 8.\n\n* * * * *\n\n ═════════════\n\nEndnotes\n\n1 General information\n\nSee [www.legislation.vic.gov.au](http://www.legislation.vic.gov.au) for Victorian Bills, Acts and current Versions of legislation and up-to-date legislative information.\n\nThe Improving Cancer Outcomes (Screening Reporting) Regulations 2018, S.R. No. 107/2018 were made on 24 July 2018 by the Governor in Council under section 28 of the **Improving Cancer Outcomes Act 2014**, No. 78/2014 and came into operation on 30 July 2018: regulation 3.\n\nThe Improving Cancer Outcomes (Screening Reporting) Regulations 2018 will sunset 10 years after the day of making on 24 July 2028 (see section 5 of the **Subordinate Legislation Act 1994**).\n\nINTERPRETATION OF LEGISLATION ACT 1984 (ILA)\n\nStyle changes\n\nSection 54A of the ILA authorises the making of the style changes set out in Schedule 1 to that Act.\n\nReferences to ILA s. 39B\n\nSidenotes which cite ILA s. 39B refer to section 39B of the ILA which provides that where an undivided regulation, rule or clause of a Schedule is amended by the insertion of one or more subregulations, subrules or subclauses the original regulation, rule or clause becomes subregulation, subrule or subclause (1) and is amended by the insertion of the expression \"(1)\" at the beginning of the original regulation, rule or clause.\n\nInterpretation\n\nAs from 1 January 2001, amendments to section 36 of the ILA have the following effects:\n\n• Headings\n\nAll headings included in a Statutory Rule which is made on or after  \n1 January 2001 form part of that Statutory Rule. Any heading inserted in a Statutory Rule which was made before 1 January 2001, by a Statutory Rule made on or after 1 January 2001, forms part of that Statutory Rule.  \nThis includes headings to Parts, Divisions or Subdivisions in a Schedule; Orders; Parts into which an Order is divided; clauses; regulations; rules; items; tables; columns; examples; diagrams; notes or forms.  \nSee section 36(1A)(2A)(2B).\n\n• Examples, diagrams or notes\n\nAll examples, diagrams or notes included in a Statutory Rule which is made on or after 1 January 2001 form part of that Statutory Rule. Any examples, diagrams or notes inserted in a Statutory Rule which was made before 1 January 2001, by a Statutory Rule made on or after 1 January 2001, form part of that Statutory Rule. See section 36(3A).\n\n• Punctuation\n\nAll punctuation included in a Statutory Rule which is made on or after  \n1 January 2001 forms part of that Statutory Rule. Any punctuation inserted in a Statutory Rule which was made before 1 January 2001, by a Statutory Rule made on or after 1 January 2001, forms part of that Statutory Rule.  \nSee section 36(3B).\n\n• Provision numbers\n\nAll provision numbers included in a Statutory Rule form part of that Statutory Rule, whether inserted in the Statutory Rule before, on or after  \n1 January 2001. Provision numbers include regulation numbers, rule numbers, subregulation numbers, subrule numbers, paragraphs and subparagraphs. See section 36(3C).\n\n• Location of \"legislative items\"\n\nA \"legislative item\" is a penalty, an example or a note. As from 13 October 2004, a legislative item relating to a provision of a Statutory Rule is taken to be at the foot of that provision even if it is preceded or followed by another legislative item that relates to that provision. For example, if a penalty at the foot of a provision is followed by a note, both of these legislative items will be regarded as being at the foot of that provision. See section 36B.\n\n• Other material\n\nAny explanatory memorandum, table of provisions, endnotes, index and other material printed after the Endnotes does not form part of a Statutory Rule. See section 36(3)(3D)(3E).\n\n2 Table of Amendments\n\nThis publication incorporates amendments made to the Improving Cancer Outcomes (Screening Reporting) Regulations 2018 by statutory rules, subordinate instruments and Acts.\n\n–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––\n\nImproving Cancer Outcomes (Screening Reporting) Amendment Regulations 2019, S.R. No. 50/2019\n\n| *Date of Making:* | 25.6.19 |\n| --- | --- |\n| *Date of Commencement:* | 1.7.19: reg. 3 |\n\n\n–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––\n\n3 Amendments Not in Operation\n\nThere are no amendments which were Not in Operation at the date of this publication.\n\n4 Explanatory details\n\n1. Reg. 4(a): S.R. No. 106/2015 as amended by S.R. No. 121/2017. [↑](#endnote-ref-1)\n\n2. Reg. 4(b): S.R. No. 121/2017. [↑](#endnote-ref-2)","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The regulations remain tightly focused on their original purpose. The 2019 amendments simplified the instrument by removing Schedule 2 (which previously prescribed information for other cancer types) and narrowing the scope exclusively to breast cancer screening. This represents a contraction rather than expansion of scope."},"complexity_factors":["Only 8 regulations plus a short schedule","Single defined term ('healthcare identifier') which simply references another Act","No nested exceptions or conditional logic","Straightforward prescriptive structure: what to report, who reports, what information to include","Minimal cross-referencing (only references to the parent Act and one Commonwealth Act)","Schedule 1 is a simple list of data fields with no legal operative provisions"],"plain_english_summary":"**What this legislation does**\n\nThese regulations set up a mandatory reporting system for breast cancer screening in Victoria. They require organisations that conduct breast screening on behalf of BreastScreen Victoria to report specific details about every screening test to the Victorian Government.\n\n**Who it affects**\n\n- **Patients**: Anyone who has a breast screening mammogram or related follow-up tests through BreastScreen Victoria\n- **Screening providers**: Organisations that perform these tests on behalf of BreastScreen Victoria\n- **The Victorian Government**: Specifically the Secretary (a senior public servant) who receives the reports\n\n**What must be reported**\n\nProviders must submit reports containing:\n- Where the test was done\n- Patient identifying information (name, address, contact details, date of birth, Indigenous status, language spoken at home)\n- The patient's healthcare identifier (a unique number used in the health system) if known\n- Family and personal history of breast cancer\n- Any symptoms the patient reported\n- What type of test was performed\n- The test results\n\n**Why it matters**\n\nThis creates a central record of breast screening across Victoria. It helps track screening rates, monitor outcomes, and improve cancer detection and treatment. The data allows health authorities to identify gaps in screening coverage and measure how well the program is working.\n\n**Key context**\n\nThese regulations sit under the *Improving Cancer Outcomes Act 2014* and replaced earlier regulations from 2015 and 2017. They have a 10-year lifespan and will expire in 2028 unless remade."},"flash_summary":{"complexity_score":3,"scope_assessment":{"changed":true,"description":"Yes. The 2019 amendment (S.R. No. 50/2019) substituted regulations 5–8 and amended Schedule 1, expressly prescribing breast screening (mammography and related follow-up) as the reportable type and limiting prescribed organisations to those conducting screening for BreastScreen Victoria. The instrument also revokes prior screening-reporting regulations, indicating a narrowing and re-specification of reporting obligations (reg 4; reg 6–8; Sch.1)."},"complexity_factors":["Narrow subject-matter: limited to breast cancer screening (mammography and related follow-up) which reduces breadth but increases specificity (reg 6; Sch.1).","Delegated reporting obligation: only organisations conducting screening on behalf of BreastScreen Victoria are prescribed to report, concentrating obligations on a defined set of providers (reg 7).","Prescribed form and data fields: Schedule 1 lists detailed personal identifiers and clinical items, creating a clear but potentially sensitive data-collection requirement (reg 8; Sch.1).","Dependency on external definitions: uses the term 'healthcare identifier' as defined in the Healthcare Identifiers Act 2010, requiring cross-referencing between instruments (reg 5).","Amendments and revocations: the instrument replaces earlier regulations and has been amended (S.R. No. 50/2019), so understanding current obligations requires attention to version history (reg 4; endnotes).","Low administrative discretion: the prescriptive nature of the form reduces interpretive flexibility but increases compliance precision (reg 8).","Privacy and compliance burden: collecting identifiers and contact details implies privacy compliance and administrative costs for reporting entities (Sch.1)."],"plain_english_summary":"These Regulations make it mandatory for organisations that carry out BreastScreen Victoria’s breast cancer screening (mammography and related radiology, pathology and clinical follow‑up) to report those tests to the Secretary in a prescribed form listing personal, clinical and test‑result details (Schedule 1). Reporting organisations bear the compliance cost; the Secretary is the recipient of the data under the Improving Cancer Outcomes Act 2014. The rule standardises what is reported and who must report."},"issue_detection":{"absurdities":[],"contradictions":[]},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"Based on the limited information available, the regulations appear to remain within the scope of their stated purpose — improving cancer outcomes through screening data reporting. No amendments or scope changes are evident from the version history provided, though the truncated document makes a definitive assessment impossible."},"complexity_factors":["The document is severely truncated — only version history metadata is visible, not the substantive regulatory content","Regulations of this type typically involve technical health data reporting obligations that can be moderately complex","Interaction with parent Act (Improving Cancer Outcomes Act) adds a layer of legislative cross-referencing","Low score reflects the narrow, administrative nature of reporting regulations generally — not typically labyrinthine","Cannot fully assess complexity without access to the full text of the regulations"],"plain_english_summary":"These Victorian 2018 regulations set out reporting rules for cancer screening programs, requiring providers, pathology services and health organisations to record and share screening information so authorities can monitor outcomes, enable follow‑up and improve early detection. They affect clinicians, labs, data custodians and, indirectly, patients whose results are tracked.\n\nNote: the available source is truncated, so specific obligations, deadlines and penalties aren’t assessable from the provided text."}},"importantCases":[],"_links":{"self":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018","history":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018/history","analysis":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018/analysis","conflicts":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018/conflicts","importantCases":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018/important-cases","documents":"/api/acts/improving-cancer-outcomes-screening-reporting-regulations-2018/documents"}}